South Dakota SB194 limits the potency of cannabis products sold at medical cannabis dispensaries.

South Dakota SB194 introduces new restrictions on the potency of cannabis products sold at medical cannabis dispensaries. The bill specifies that dispensaries may not sell products exceeding certain tetrahydrocannabinol (THC) levels: thirty percent for cannabis flower, sixty percent for liquid concentrate products, five milligrams per serving for edible products, one hundred milligrams per container for edible products, and five percent for cannabis oil. These limits aim to regulate the strength of cannabis products available for medical use.

South Dakota SB194 limits the potency of cannabis products sold at medical cannabis dispensaries.

South Dakota SB194 introduces new restrictions on the potency of cannabis products sold at medical cannabis dispensaries. The bill specifies that dispensaries may not sell products exceeding certain tetrahydrocannabinol (THC) levels: thirty percent for cannabis flower, sixty percent for liquid concentrate products, five milligrams per serving for edible products, one hundred milligrams per container for edible products, and five percent for cannabis oil. These limits aim to regulate the strength of cannabis products available for medical use.